RxDoctor Payments Data

Allen Ciuffo, MD

Cardiovascular Disease · Norfolk, VANPI 1649243502

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,663 of the $3,851 with a category attached, or 69.2%. Boston Scientific accounts for 87.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $1,762 and has fallen 90.3% since, to $172 in 2025.

$3,851in general payments, 2019–2025

Across 52 payments — averaging $74.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Medtronic$188
  • Abiomed$140
  • Cvrx, Inc.$118
  • Abbott$23
$236,800in research payments, 2019–2025

Across 53 payments — averaging $4467.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$205K
  • Abbott$17K
  • Medtronic$15K

What the payments were for

  • Travel & lodging$2,66369%
  • Food & beverage$1,18831%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific46$3,380
Medtronic3$188
Abiomed1$140
Cvrx, Inc.1$118
Abbott1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,851 in reported general payments places this provider in the 70th percentile of 548 cardiovascular disease providers in Virginia.

See all cardiovascular disease providers in Virginia

Medicare billing

Part B allowed, 2024
$300,216
Medicare patients
1,706
Services billed
4,700

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$69,630
Metoprolol Succinate40$822
Carvedilol48$469
Warfarin Sodium29$433
Rosuvastatin Calcium22$343
Atorvastatin Calcium27$321
Nitroglycerin13$289
Furosemide42$268
ClopidogrelClopidogrel Bisulfate12$233
Lisinopril35$196
Losartan Potassium18$150
Spironolactone11$95
Metoprolol Tartrate26$75
Sildenafil Citrate15$68
Amlodipine Besylate11$22

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →